A 45-year-old-Female Successfully Treats General Anxiety Disorder & Agoraphobia with the CES Ultra
I have been treating the patient for generalized anxiety disorder and agoraphobia for approximately three weeks. She has been having increasing difficulty with this system complex for approximately three years. Stopping the use of nicotine, alcohol, and most caffeine proved not to be therapeutic. She has also had clinical trials of beta blockers and MAO inhibitors without success. In the past, a hypoglycemic diagnosis was made by glucose tolerance test, but a therapeutic diet has not been found effective in stopping this symptom complex. A work-up for mitral valve prolapse, including EKG and ultrasound by a cardiologist, has proven to be negative.
With the continuing progress of these symptoms increasingly limiting not only her personal activities but also her public related business activities, we elected for a clinical trial of Cranial Electrotherapy Stimulation (CES) therapy.
For the first time in three years, she is now experiencing uninterrupted sleep of eight-to-twelve hours duration, depending on her level of fatigue at bedtime. Her anxiety episodes have been reduced by approximately 80 percent. Her depression, though still present, has been reduced by approximately 50 percent and her overall ability to be out of her home, making social contacts of a personal or business nature has improved significantly as well. Given that this therapy has essentially no side effects and has proven to be so efficacious in this patient, I have recommended that she continue daily use of the CES unit, a minimum of 20 minutes per day, for at least the next six to twelve months.
Contact us today to learn more about how the CES Ultra can help you relax, enjoy restful sleep, and find greater peace of mind.